A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way.

The Therapeutic Goods Administration has received complaints of blindness and vision loss in one eye among users of Ozempic and Wegovy, who are reluctant to ditch the weight-loss drugs.

It contains tirzepatide and is licensed for use beyond diabetes. Ozempic, on the other hand, contains semaglutide and is approved in the UK only for type 2 diabetes—not weight loss. But some ...

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle with giants Eli Lilly and Novo Nordisk for a share of the multibillion-dollar ...

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is ...

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to ...

Carnie Wilson will not be turning to Ozempic for weight loss anytime soon. During an interview with Fox News Digital, Wilson, who previously lost more than 100 pounds with gastric bypass and lap ...

Are you on Ozempic or planning on taking it or another similar GLP-1 weight loss drug? There are some side effects to look out for. Karli Sine is a social media influencer who lost 55+ lbs on ...

Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar. These injectable medications, originally developed for type 2 diabetes, ...